Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,796.00
(
0.00%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
110.51
(
3.68%
)
Bitcoin
70,321.74
(
-1.31%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 70286

Wednesday, 03/04/2009 11:15:26 PM

Wednesday, March 04, 2009 11:15:26 PM

Post# of 257257
Re: NKTR's PEGylation platform

Robin sold the respiratory stuff to NVS for a cool $115M; however, I’m not a big fan of NKTR’s PEGylation platform, which is all that’s left.



Dew, if I may, what is it that you don't like about NKTR's PEGylation platform? I'm following it now and am just curious. The Phase II data on NKTR-118 in opiod-induced constipation appeared to be pretty good.

TIA
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now